IsoRay, Inc.
350 Hills Street
Suite 106
Richland,
WA 99352
United States - Map
Phone: 509-375-1202
Fax: 509-375-3473
Web Site: http://www.isoray.com
| IsoRay, Inc. engages in the development, manufacture, and sale of isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. It primarily produces Proxcelan Cesium-131 brachytherapy seeds, which are used in the treatment of prostate cancer; ocular melanoma; head, neck, and lung tumors; and breast, liver, brain, and pancreatic cancers. The company is headquartered in Richland, Washington. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Dwight Babcock , 61
Chairman and Chief Exec. Officer |
N/A
| N/A | Ms. Lori Holmes-Woods , 47
Chief Operating Officer and VP of Marketing |
N/A
| N/A | Mr. Jonathan R. Hunt , 42
Consultant |
$
144.00K | N/A | Mr. Robert Bilella ,
Territory Sales Mang. |
N/A
| N/A | Mr. Brien Ragle , 40
Principal Financial Officer, Principal Accounting Officer and Controller |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.51% Nasdaq 
0.02 (2.25%) 
Profile
